Applied Clinical Trials published an article co-written by Signify Health's Chief Medical Officer Marc Rothman, MD and Mignon Loh, MD, Children's Oncology Group All Committee Chair, that examines how bringing clinical trials to patients' homes can address existing site-based challenges.
Signify Health is working with Children’s Oncology Group to expand in-home research and care options for investigational immune-oncology therapy.
4 min read
Children’s Oncology Group and Signify Health Collaborate to Broaden In-Home Administration for Investigational Immuno-oncology Therapy for Patients Enrolled in COG AALL1731
MONROVIA, CA, and DALLAS, TX, June 17, 2021 — The Children’s Oncology Group (COG), the world's largest organization devoted exclusively to childhood and adolescent cancer research, and Signify Health, Inc. (NYSE:SGFY), a leading platform that leverages advanced analytics, technology and nationwide healthcare provider networks, today announced a partnership to facilitate clinical trial participation for pediatric patients through in-home clinical services.
4 min read
Parexel and Signify Health Collaborating to Develop New Solutions to Promote Access and Inclusion in Clinical Trials
BOSTON, DURHAM, N.C. and DALLAS – Jan. 13, 2021 – Parexel and Signify Health today announced a strategic collaboration to provide customers with new solutions to enable access to a more diverse and traditionally underrepresented population for their clinical trials. The partnership will focus on improving patient access to clinical trials, bringing studies to patients in their own homes, and identifying relevant social determinants of health (SDoH) to facilitate connections among local resources, patients, and caregivers.
3 min read
Signify Health’s Biopharmaceutical Clinical and Caregiver Support Services Remove Barriers to Treatment Associated with Complex Drug Therapies
Home-based services help patients initiate therapy sooner, thrive on therapy longer and have a more satisfying experience